ALEXANDRIA REAL ESTATE EQUITIES, INC. (ARE) Latest Filing Signal

Latest Filing: 10-K  |  Filed Jan 26, 2026

Cross-checked across multiple AI analysts and grounded in the latest SEC filing.

powered by: earningsVibe.ai

Question:
What is the latest filing signal for ALEXANDRIA REAL ESTATE EQUITIES, INC.?
Answer:
Based on earningsVibe SuperAnalyst™ synthesis of the latest 10-K, ALEXANDRIA REAL ESTATE EQUITIES, INC.'s filing signal turned negative.
earningsVibe SuperAnalyst™ Verdict: TURNED NEGATIVE

Signal Performance — Stock Price Since Filing

30-Day Change
-5.42%
from filing date
60-Day Change
-19.45%
from filing date

Underlying analyst views from Perplexity, Gemini, Claude, and ChatGPT

PERPLEXITY
Continuing Negative
GEMINI
Turned Negative
CLAUDE
Turned Negative
CHATGPT
Continuing Negative

Unlock the Full Filing Analysis

See full earningsSig™ and risksSig™ analysis across 5,000+ companies

Get Started Free →

No credit card required

Question:
What does ALEXANDRIA REAL ESTATE EQUITIES, INC. actually do?
Answer:
Alexandria Real Estate Equities, Inc. is a life science REIT that pioneered the life science real estate niche in 1994. The company is a leading owner, operator, and developer of collaborative "Megacampus" ecosystems in key life science innovation clusters across North America, including Greater Boston, the San Francisco Bay Area, and San Diego. Alexandria's properties are designed to foster innovation and attract top talent, serving a diverse tenant base ranging from multinational pharmaceutical companies to biotechnology firms and academic institutions. The company also provides strategic capital to life science companies through its venture capital platform. As of December 31, 2025, Alexandria owned approximately 39.4 million RSF of operating properties and new development properties under construction, with an occupancy rate of 90.9% for its operating properties.
Question:
What are ALEXANDRIA REAL ESTATE EQUITIES, INC.'s revenue drivers?
Answer:
Revenue is primarily driven by rental income from its portfolio of life science properties. The company also generates revenue from tenant recoveries for operating expenses and from its non-real estate investments.

Cut through noisy SEC filings to find the signal faster

Source-grounded filing intelligence with one-click links back to the filing, so you can move faster and verify everything at the source.

Get Started Free →

No credit card required